Recursion Pharmaceuticals (RXRX) just moved onto many investors’ radar after Sanofi optioned the first development candidate ...

Recursion Pharmaceuticals reported past pipeline and collaboration progress, including positive REC-4881 and REC-1245 trial ...

Cathie Wood’s Ark Invest increased its exposure to AI infrastructure, digital platforms, and biotechnology, led by purchases ...

Recursion Pharmaceuticals Inc. stocks have been trading up by 3.85 percent after upbeat AI-driven drug discovery partnership ...

On the X platform, discussions are currently underway regarding lattice-based cryptography and hash-based cryptography in ...

The evolution of the harness layer represents a pivotal, technology-driven progression in modern engineering systems, ...

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from seri ...

The discussion highlights a growing focus across the crypto industry on ensuring that major blockchains remain secure as ...

This press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Google Research published a paper on October 9 and open-sourced the Harness² framework on GitHub under the Apache 2.0 license. The framework ...

Many complex behaviors have resisted mechanistic explanations. Deciphering them requires new approaches—and maybe a new ...

This Applied AI edition looks at what organizations actually did with AI over the past two weeks, drawn from our Use-Case Library and from SEC ...